ACUTE AND CHRONIC OSTEOMYELITIS: ETIOLOGY, CLINICAL MANIFESTATIONS, PATHOPHYSIOLOGY, AND MODERN TREATMENT APPROACHES
Keywords:
Osteomyelitis, acute infection, chronic infection, bone necrosis, pathophysiology, Staphylococcus aureus, inflammation, sequestrum.Abstract
Osteomyelitis represents a severe inflammatory condition of bone tissue caused predominantly by microbial infection, characterized by progressive destruction, necrosis, and potential systemic complications. This study aims to provide a comprehensive theoretical and analytical overview of acute and chronic osteomyelitis, focusing on etiology, clinical presentation, pathophysiological mechanisms, and contemporary treatment strategies. Acute osteomyelitis is typically associated with hematogenous bacterial dissemination, most commonly involving Staphylococcus aureus, whereas chronic osteomyelitis develops due to inadequate treatment or persistence of infection, leading to sequestrum formation and long-term morbidity. The pathophysiology involves complex interactions between microbial virulence factors, host immune responses, vascular compromise, and bone remodeling dynamics. Clinically, acute osteomyelitis presents with localized pain, fever, swelling, and systemic inflammatory signs, while chronic osteomyelitis is characterized by sinus tract formation, intermittent discharge, and persistent bone destruction. Epidemiological data suggest increasing incidence rates due to trauma, surgical interventions, and comorbid conditions such as diabetes mellitus. Modern treatment approaches emphasize early diagnosis using advanced imaging techniques and laboratory markers, combined with targeted antimicrobial therapy and surgical debridement when necessary. Emerging strategies include biofilm disruption, local antibiotic delivery systems, and regenerative bone therapies. Multidisciplinary management has significantly improved patient outcomes, although challenges remain in preventing recurrence and managing resistant infections
References
1. Calhoun, J. H., & Manring, M. M. (2005). Adult osteomyelitis. Infectious Disease Clinics of North America, 19(4), 765–786. https://doi.org/10.1016/j.idc.2005.07.009
2. Cierny, G., & Mader, J. T. (2003). Adult chronic osteomyelitis: Classification and treatment. Orthopedics, 26(1), 1–6.
3. Conterno, L. O., & Turchi, M. D. (2013). Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database of Systematic Reviews, 2013(9), CD004439. https://doi.org/10.1002/14651858.CD004439.pub3
4. Darley, E. S. R., & MacGowan, A. P. (2004). Antibiotic treatment of osteomyelitis: What have we learned from 30 years of clinical trials? Journal of Antimicrobial Chemotherapy, 53(6), 928–935. https://doi.org/10.1093/jac/dkh168
5. Glaudemans, A. W. J. M., Signore, A., & Jutte, P. C. (2019). Nuclear medicine imaging of osteomyelitis. European Journal of Nuclear Medicine and Molecular Imaging, 46(5), 1205–1216. https://doi.org/10.1007/s00259-018-4239-7
6. Kremers, H. M., Nwojo, M. E., Ransom, J. E., Wood-Wentz, C. M., Melton, L. J., & Huddleston, P. M. (2015). Trends in the epidemiology of osteomyelitis: A population-based study. The Journal of Bone and Joint Surgery, 97(10), 837–845. https://doi.org/10.2106/JBJS.N.01350
7. Lazzarini, L., Mader, J. T., & Calhoun, J. H. (2004). Osteomyelitis in long bones. The Journal of Bone and Joint Surgery, 86(10), 2305–2318.
8. Lew, D. P., & Waldvogel, F. A. (2004). Osteomyelitis. The Lancet, 364(9431), 369–379. https://doi.org/10.1016/S0140-6736(04)16727-5
9. Lipsky, B. A., Berendt, A. R., & Cornia, P. B. (2012). 2012 Infectious Diseases Society of America clinical practice guideline for diabetic foot infections. Clinical Infectious Diseases, 54(12), e132–e173. https://doi.org/10.1093/cid/cis346
10. Mader, J. T., Ortiz, M., & Calhoun, J. (1999). Update on the diagnosis and management of osteomyelitis. Clinical Podiatric Medicine and Surgery, 16(1), 1–24.
11. Metsemakers, W. J., Kuehl, R., Moriarty, T. F., Richards, R. G., Verhofstad, M. H. J., Borens, O., & Kates, S. L. (2018). Infection after fracture fixation: Current surgical and microbiological concepts. The Lancet Infectious Diseases, 18(2), e1–e12. https://doi.org/10.1016/S1473-3099(17)30483-9
12. Parsons, B., Strauss, E., & Napoli, N. (2017). Biofilm in chronic osteomyelitis. Injury, 48(1), S7–S12. https://doi.org/10.1016/S0020-1383(17)30491-0
13. Peltola, H., & Pääkkönen, M. (2014). Acute osteomyelitis in children. New England Journal of Medicine, 370(4), 352–360. https://doi.org/10.1056/NEJMra1213956
14. Shirtliff, M. E., & Mader, J. T. (2002). Acute septic arthritis and osteomyelitis in children. Clinical Microbiology Reviews, 15(4), 527–544. https://doi.org/10.1128/CMR.15.4.527-544.2002
15. Tice, A. D., Hoaglund, P. A., & Nolet, B. (2003). Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Clinical Infectious Diseases, 36(6), 724–729. https://doi.org/10.1086/367842
16. Trampuz, A., & Zimmerli, W. (2006). Prosthetic joint infections: Update in diagnosis and treatment. Swiss Medical Weekly, 136(17–18), 243–251.
17. Waldvogel, F. A., Medoff, G., & Swartz, M. N. (1970). Osteomyelitis: A review of clinical features and therapeutic considerations. Medicine, 49(2), 89–110.
18. Zimmerli, W. (2010). Clinical practice: Osteomyelitis. New England Journal of Medicine, 362(11), 1022–1029. https://doi.org/10.1056/NEJMcp0910753
19. Brady, R. A., Leid, J. G., Costerton, J. W., Shirtliff, M. E. (2008). Osteomyelitis and the role of biofilms in chronic infection. Future Microbiology, 3(5), 517–530. https://doi.org/10.2217/17460913.3.5.517
20. Lewallen, D. G. (1998). Management of bone infections. Orthopedic Clinics of North America, 29(1), 1–12.
